RxMapper identifies personalized medications based on a patient's unique DNA, resulting in better health outcomes and lower costs.
RxMapper has raised $8.2M in total funding. The most recent round was Seed. The last funding was announced in November 2022.
RxMapper is headquartered in Scottsdale, United States.
RxMapper identifies personalized medications based on a patient's unique DNA, resulting in better health outcomes and lower costs.
RxMapper is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RxMapper — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/rxmapper. Accessed August 14, 2026.
VCBacked. (2022). RxMapper — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rxmapper
{{cite web |title=RxMapper — Funding & Investors |url=https://www.vcbacked.co/company/rxmapper |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated